Idera Pharma (IDRA) Reports Q3 Loss of $0.10/Share

Idera Pharma (NASDAQ: IDRA) reported Q3 EPS of ($0.10), versus ($0.11) reported last year. Revenue for the quarter came in at $20 thousand, versus $30 thousand reported last year.

For earnings history and earnings-related data on Idera Pharma (IDRA) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c